AstraZeneca PLC header image

AstraZeneca PLC

AZN

Equity

ISIN GB0009895292 / Valor 982352

LSE London Stock Exchange, SETS (2026-09-08)

GBP 118.76-1.38%

AstraZeneca PLC
UMushroom community rating:

4.05 20 votes No rating yet

NegativeNeutralPositive

About company

AstraZeneca PLC is a global pharmaceutical company with a focus on the discovery, development, and commercialization of prescription medicines across various therapy areas. The company is science-led and patient-focused, aiming to address unmet medical needs by bringing innovative medicines to market. AstraZeneca operates in key therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology, with a growing pipeline in rare diseases. Its business strategy emphasizes growth through innovation, leveraging advanced therapeutic modalities and engaging in strategic partnerships to enhance healthcare outcomes. AstraZeneca's commitment to healthcare extends to improving access to its medicines globally, ensuring it plays a significant role in transforming the future of healthcare.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-0.79%1Y

9.50%3Y

42.8%5Y

Performance

27.7%1Y

25.1%3Y

24.6%5Y

Volatility

249300 M

Market cap (USD)

2,041,873

Daily traded volume (Shares)

104.82 / 103.6

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.05

20 votes

Performance:

3.66

Innovation:

4.24

Society:

3.74

Nature:

3.39

Aran Grant

UK, 09 Nov 2025

Health stocks nice and stable

Deny Purwanto

UK, 09 Nov 2025

.

Korbinian Kramer

UK, 08 Nov 2025

Strong growth due to the comapnies strength in innovation and high drug demand

EQUITIES OF THE SAME SECTOR

Draegerwerk AG & Co. KGaA

Draegerwerk AG & Co. KGaA Valor: 330445

Annual Return

-50%0%+50%

Risk level

110

0.48%EUR 83.20

aap Implantate AG

aap Implantate AG Valor: 57872565

Annual Return

-50%0%+50%

Risk level

110

0.00%EUR 1.75

Alcon Inc.

Alcon Inc. Valor: 43249246

Annual Return

-50%0%+50%

Risk level

110

-2.00%CHF 55.82

Straumann Holding Ltd

Straumann Holding Ltd Valor: 117544866

Annual Return

-50%0%+50%

Risk level

110

0.60%CHF 93.58

BACHEM HOLDING LTD

BACHEM HOLDING LTD Valor: 117649372

Annual Return

-50%0%+50%

Risk level

110

2.14%CHF 78.60

Tecan Group Ltd.

Tecan Group Ltd. Valor: 1210019

Annual Return

-50%0%+50%

Risk level

110

0.41%CHF 197.80

Galenica Ltd.

Galenica Ltd. Valor: 36067446

Annual Return

-50%0%+50%

Risk level

110

0.73%CHF 83.25

Idorsia Ltd

Idorsia Ltd Valor: 36346343

Annual Return

-50%0%+50%

Risk level

110

0.89%CHF 5.13

Siegfried Holding Ltd

Siegfried Holding Ltd Valor: 1428449

Annual Return

-50%0%+50%

Risk level

110

2.52%CHF 71.30

AEVIS VICTORIA SA

AEVIS VICTORIA SA Valor: 47863410

Annual Return

-50%0%+50%

Risk level

110

0.39%CHF 12.75

SIX

FactSet

Clearbit

Logos provided by Clearbit